From August 16, 2023 to September 30, 2023, the company has repurchased 400,000 shares, representing 0.51% for CNY 22.64 million. With this, the company has completed the repurchase of 400,000 shares, representing 0.51% for CNY 22.64 million under the buyback announced on August 17, 2023.
Hangzhou Alltest Biotech Co., Ltd.
Equities
688606
CNE1000053G6
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.45 CNY | -0.36% | -1.61% | -32.29% |
Apr. 29 | China, HK stocks rise, led by property shares | RE |
Apr. 26 | Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-32.29% | 495M | |
-8.55% | 11.78B | |
-22.07% | 6.59B | |
+27.13% | 5.46B | |
-24.14% | 3.45B | |
+4.11% | 2.5B | |
+31.97% | 2.29B | |
-67.03% | 2.21B | |
-12.07% | 2.2B | |
-17.96% | 1.59B |
- Stock Market
- Equities
- 688606 Stock
- News Hangzhou Alltest Biotech Co., Ltd.
- Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.